Listed

Hackett Group, Inc.: Form 10-Q for the period ended Jul 1, 2022

Filed with the SEC on Aug 10, 2022 and accepted by EDGAR at Aug 10, 2022, 15:25 ET.

Share

Management's discussion and analysis

As filed, 19,186 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in these sections. All statements regarding our expected financial position and operating results, our business strategy, our financing plans and forecasted demographic and economic trends relating to our industry are forward-looking statements. These statements can sometimes be identified by our use of forward-looking words such as “may,” “will,” “anticipate,” “estimate,” “expect,” or “intend” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. We cannot promise you that our expectations reflected in such forward-looking statements will turn out to be correct. Factors that could impact such forward-looking statements include, among others, the impact of the coronavirus (COVID-19) pandemic and our ability to mitigate or manage disruptions posed by COVID-19 pandemic, changes in worldwide and U.S. economic conditions that impact business confidence and the demand for our products and services, our ability to effectively integrate acquisitions into our operations, our ability to retain existing business, our ability to attract additional business, our ability to effectively market and sell our product offerings and other services, the timing of projects and the potential for contract cancellation by our customers, changes in expectations regarding the business consulting and information technology industries, our ability to attract and retain skilled employees, possible changes in collections of accounts receivable due to the bankruptcy or financial difficulties of our customers, risks of competition, price and margin trends, foreign currency fluctuations, the impact of the geopolitical conflict involving Russia and Ukraine on our business and changes in general economic conditions, inflation, interest rates and our ability to obtain additional debt financing if needed. For a discussion of risks and actions taken in response to the COVID-19 pandemic, see “Our results of operations have been adversely affected and could in the future be materially adversely impacted by the coronavirus pandemic (COVID-19)” under Item 1A, “Risk Factors” of our Annual Report on Form 10-K. An additional description of our risk factors is described in Part I – Item 1A, “Risk Factors”. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Many of the risks, uncertainties and other factors identified in our Annual Report on Form 10-K for the year ended December 31, 2021 have been amplified by the COVID-19 pandemic.

OVERVIEW

The following Management's Discussion and Analysis ("MD&A") is intended to help the reader understand the results of operations and financial condition of Hackett. MD&A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q.

The Hackett Group, Inc. (“Hackett” or the “Company”) is a leading IP-based strategic advisory and technology consulting firm that enables companies to achieve world-class business performance. By leveraging the comprehensive Hackett database, the world’s leading repository of enterprise business process performance metrics and best practice intellectual capital, our business and technology solutions help clients improve performance and maximize returns on technology investments. Only Hackett empirically defines world-class performance in sales, general and administrative and certain supply chain activities with analysis gained through nearly 20,000 benchmark and performance studies over 27 years at over 7,000 of the world’s leading companies.

In the following discussion, Strategy and Business Transformation Group includes the results of our North America IP as-a-service offerings, which include our Executive Advisory Programs and Benchmarking Services, and our Business Transformation Practices (S&BT). ERP, EPM and Analytics Solutions includes the results of our North America Oracle EEA and SAP Solutions Practices (EEA). International includes results of our S&BT and EEA Practices primarily in Europe.

COVID-19 Pandemic Impact on Our Business

The level of revenue we achieve is based on our ability to deliver market leading services and solutions and to deploy skilled teams of professionals quickly. Our results of operations are affected by economic conditions, including macroeconomic conditions and levels of business confidence. In each of the four quarters of 2021, our revenue before reimbursements and diluted earnings per share grew when compared to the fourth quarter of 2020 reflecting a continuation of improved economic conditions. However, any reversal of these trends or a prolonged economic downturn as a result of the impact of COVID-19 variants, or otherwise, weak or uncertain economic conditions or similar factors could adversely affect our clients' financial condition which may further reduce our clients' demand for our services.

We are actively managing our business to respond to the impact of the COVID-19 pandemic. We are generally following the requirements and protocols published by the U.S. Centers for Disease Control and the World Health Organization, and state and local governments.

In light of the evolving health, social, economic and business environment, governmental regulations or mandates, and business disruptions that could occur, the potential impact that the COVID-19 pandemic could have on our financial condition and operating results remains highly uncertain.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, our results of operations(in thousands and unaudited):

Revenue: Quarter Ended July 1, 2022 July 2, 2021 Six Months Ended July 1, 2022 July 2, 2021
Revenue before reimbursements $74,768 $72,997 $149,876 $136,407
Reimbursements 1,160 200 1,716 276
Total revenue 75,928 73,197 151,592 136,683
Costs and expenses:
Cost of service:
Personnel costs before reimbursable expenses (includes $1,483 and $3,149 and $1,779 and $3,626 of stock compensation expense in the three and six months ended July 1, 2022 and July 2, 2021, respectively) 44,701 43,227 92,034 84,397
Reimbursable expenses 1,160 200 1,716 276
Total cost of service 45,861 43,427 93,750 84,673
Selling, general and administrative costs (includes $1,235 and $2,168 and $874 and $1,614 of stock compensation expense in the three and six months ended July 1, 2022 and July 2, 2021, respectively) 15,886 15,553 30,252 28,940
Total costs and operating expenses 61,747 58,980 124,002 113,613
Income from operations 14,181 14,217 27,590 23,070
Other expense:
Interest expense (28) (25) (56) (50)
Income from continuing operations before income taxes 14,153 14,192 27,534 23,020
Income tax expense 3,938 3,660 6,814 6,120
Income from continuing operations 10,215 10,532 20,720 16,900
Loss from discontinued operations — — — (7)
Net income $10,215 $10,532 $20,720 $16,893
Diluted net income per common share $0.32 $0.32 $0.65 $0.51

Revenue. We are a global company with operations located in the United States and Western Europe. Our revenue is denominated in multiple currencies, primarily the U.S. Dollar, British Pound and Euro, and as a result is affected by currency exchange rate fluctuations. The impact of currency fluctuations did not have a significant impact on comparisons between the second quarter and first six months of 2022 and the comparable periods of 2021. In this MD&A, we discuss revenue based on geographical location of engagement team personnel.

The following table sets forth revenue by group for the periods indicated (in thousands):

Quarter Ended July 1, 2022 July 2, 2021 Six Months Ended July 1, 2022 July 2, 2021
S&BT $33,390 $26,496 $63,370 $52,255
EEA 36,774 40,673 74,739 72,865
International 5,764 6,028 13,483 11,563
Total revenue $75,928 $73,197 $151,592 $136,683

17

Our Company total revenue increased 4%, to $75.9 million, and 11%, to $151.6 million in the second quarter and first six months of 2022, as compared to $73.2 million, and $136.7 million, in the same periods of 2021, respectively. In the second quarter and first six months of 2022, one customer accounted for 7% of our total revenue. In the second quarter of 2021 one customer accounted for 7% of our total revenue and in the first six months of 2021 no customer accounted for more than 5% of our total revenue.

S&BT total revenue was $33.4 million and $63.4 million during the second quarter and first six months of 2022, respectively, as compared to $26.5 million and $52.3 million in the same period of 2021, reflecting the continued sequential growth since the second quarter of 2020.

EEA total revenue was $36.8 million and $74.7 million during the second quarter and first six months of 2022, respectively, as compared to $40.7 million and $72.9 million in the same periods of 2021. EEA total revenue in the second quarter and first six months of 2021 included a a $5.3 million software sales transaction. EEA total revenue, excluding the software transaction, was $35.4 million and $67.6 million in the second quarter and first six months of 2021, respectively. The increase in revenue in 2022 as compared to 2021, excluding the software sale transaction, was primarily driven by large ERP and EPM Oracle engagements and continuing growth of our OneStream implementation offerings; partially offset by a decline in our SAP offerings as we are rebuilding our sales pipeline after the completion of large SAP related engagements.

Hackett international total revenue decreased 4% in the second quarter of 2022 and increased 17% during the first six months of 2022, respectively, as compared to the same periods in 2021. The increase in total revenue was primarily due to U.S. driven global engagements. The Company’s international total revenue accounted for 8% and 9% of Company total revenue during the second quarter and first six months of 2022, respectively, and 8% for both of the comparable periods in 2021.

Reimbursements as a percentage of Company total revenue were 1.5% and 1.1% during the second quarter and first six months of 2022, respectively, as compared to 0.3% and 0.2%, in the same periods in 2021. Reimbursements are project travel-related expenses passed through to a client with no associated operating margin. We have experienced increased client-related travel since the transition to a remote delivery model, however we do not expect reimbursements to return to pre-pandemic levels.

Cost of Service. Cost of service consists of personnel costs before reimbursable expenses, which includes salaries, benefits and incentive compensation for consultants and subcontractor fees, acquisition-related cash and stock compensation costs, non-cash stock compensation expense, and reimbursable expenses which are travel and other expenses passed through to a client and are associated with projects.

Personnel costs before reimbursable expenses, increased 3% to $44.7 million and 9% to $92.0 million, for the second quarter and first six months of 2022 respectively, as compared to $43.2 million and $84.4 million in the same periods of 2021. The higher costs in the six-month period of 2022 were primarily a result of hiring activities and increased utilization of subcontractors to support revenue growth, as well as increases in incentive compensation accruals commensurate with Company performance. Personnel costs as a percentage of total revenue were 59% and 61% for the second quarter and first six months of 2022, respectively, as compared to 59% and 62% for the same periods of 2021, respectively.

Non-cash stock compensation expense, included in personnel costs before reimbursable expenses was $1.5 million and $3.1 million for the second quarter and first six months of 2022, respectively, as compared to $1.8 million and $3.6 million for the same periods of 2021, respectively.

Acquisition related non-cash stock compensation expense, included in personnel costs before reimbursable expenses, was $4 thousand and $8 thousand for the second quarter and first six months of 2022, respectively, as compared to $111 thousand and $359 thousand for the same periods of 2021, respectively, primarily related to equity issued in relation to acquisitions.

Selling, General and Administrative Costs (“SG&A”). SG&A primarily consists of salaries, benefits and incentive compensation for the selling, marketing, administrative and executive employees, non-cash compensation expense, amortization of intangible assets, acquisition related costs and various other overhead expenses.

SG&A costs increased 2%, to $15.9 million and 5%, to $30.3 million, for the second quarter and first six months of 2022, respectively, as compared to $15.6 million and $28.9 million for the same periods of 2021, respectively. This increase in the costs during the first six months of 2022 was primarily due to increased incentive compensation accruals commensurate with Company performance, increased professional fees and increased investments in sales and marketing. SG&A costs as a percentage of total revenue were 21% and 20% during the second quarter and first six months of 2022, as compared to 21% for both of the same periods in 2021.

Non-cash stock compensation expense, included in SG&A, was $1.2 million and $2.2 million for the second quarter and first six months of 2022, respectively, as compared to $0.9 million and $1.6 million for the same periods of 2021, respectively. The increase is due to higher incentive compensation expense commensurate with Company performance.

Amortization expense, included in SG&A, was $10 thousand and $154 thousand million in the second quarter and first six months of 2022, respectively, as compared to $0.3 million and $0.5 million in the same periods in 2021, respectively. The amortization expense related to the amortization of the intangible asset acquired in our acquisitions and the buyout of our partner’s joint venture interest in the CGBS Training and Certification Programs in 2017. As of July 1, 2022, the intangible assets related to the acquisitions have been fully amortized.

Income Taxes. During the second quarter and first six months of 2022, we recorded $3.9 million and $6.8 million of income tax expense, respectively, related to certain federal, foreign and state taxes which reflected an effective tax rate of 28% and 25%, respectively. In the second quarter and first six months of 2021, we recorded $3.7 million and $6.1 million of income tax expense related to certain federal, foreign and state taxes which reflected an effective tax rate of 26% and 27%, respectively.

Liquidity and Capital Resources

As of July 1, 2022, and December 31, 2021, we had $61.7 million and $45.8 million, respectively, classified in cash on the consolidated balance sheets. We currently believe that available funds (including the cash on hand and funds available for borrowing under our credit facility) and cash flows generated by operations will be sufficient to fund our working capital and capital expenditure requirements, including working capital, debt payments, lease obligations and capital expenditures for at least the next twelve months and beyond. We may decide to raise additional funds in order to fund expansion, to develop new or further enhance products and services, to respond to competitive pressures, or to acquire complementary businesses or technologies. There is no assurance that additional financing would be available when needed or desired. Our cash requirements have not changed materially from those disclosed in Item 7 included in Part II of our Annual Report on Form 10-K for the year ended December 31, 2021.

The following table summarizes our cash flow activity (in thousands):

Six Months Ended July 1, 2022 July 2, 2021
Cash flows provided by operating activities $24,289 $19,651
Cash flows used in investing activities $(2,267) $(1,417)
Cash flows used in financing activities $(6,100) $(15,219)

Cash Flows from Operating Activities

Net cash provided by operating activities was $24.3 million during the first six months of 2022, as compared to $19.7 million during the same period in 2021. In 2022, the net cash provided by operating activities was primarily due to net income adjusted for non-cash items, partially offset by the decrease in accounts payable and accrued liabilities and other accruals primarily due to the payout of vendor payments and the 2021 incentive compensation payments. In 2021, the net cash provided by operating activities was primarily due to net income adjusted for non-cash items and an increase in accounts payable, incentive compensation and income tax accruals, partially offset by an increase in accounts receivable and contract assets.

Cash Flows from Investing Activities

Net cash used in investing activities was $2.3 million during the first six months of 2022, as compared to $1.4 million during the same period in 2021. During both periods, cash flows used in investing activities primarily related to investments for the development of our Quantum Leap benchmark technologies. The investing activities in 2022 also included purchases of computer equipment.

Cash Flows from Financing Activities

Net cash used in financing activities was $6.1 million and $15.2 million during the first six months of 2022 and 2021, respectively. The usage of cash in the first six months 2022 primarily related to the repurchase of $3.1 million of the Company's common stock and dividend payments of $3.5 million. The usage of cash in the first six months 2021 primarily related to the repurchase of $12.4 million of the Company’s common stock and dividend payments of $3.3 million.

As of July 1, 2022, we did not have any outstanding borrowings under our revolving line of credit (the “Revolver”), leaving us with a capacity of approximately $45.0 million. See Note 7, “Credit Facility,” to our consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.

Market risk

As filed, 1,317 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of July 1, 2022, our exposure to market risk related primarily to changes in interest rates and foreign currency exchange rate risks.

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to the Revolver, which is subject to variable interest rates. Under our current credit agreement which expires in November 2022, the interest rates per annum applicable to loans under the Revolver will be, at our option, equal to either a base rate or a LIBOR rate for one-, two-, three- or nine-month interest periods chosen by us in each case, plus an applicable margin percentage. A 100-basis point increase in our interest rate under our Revolver would not have had a material impact on our results of operations for the quarter and six months ended July 1, 2022. Upon renewal of our credit agreement in November 2022, the interest rate will change from LIBOR to a different benchmark index, which is yet to be determined.

Exchange Rate Sensitivity

We face exposure to adverse movements in foreign currency exchange rates as a portion of our revenue, expenses, assets and liabilities are denominated in currencies other than the U.S. Dollar, primarily the British Pound, the Euro and the Australian Dollar. These exposures may change over time as business practices evolve.

Controls and procedures

As filed, 872 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Controls

There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 387 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For a discussion of our potential risks and uncertainties, see the risk factor below and the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”).

There have been no material changes to any of the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-07-01. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-02 to 2022-07-01$75.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-01-01 to 2022-07-01$151.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-02 to 2022-07-01$45.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2022-01-01 to 2022-07-01$93.8mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2022-04-02 to 2022-07-01$15.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-01-01 to 2022-07-01$30.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-02 to 2022-07-01$14.2mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-07-01$27.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-02 to 2022-07-01$28.0kus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-07-01$56.0kus-gaap:InterestExpense
Income tax3 months2022-04-02 to 2022-07-01$3.9mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-07-01$6.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-02 to 2022-07-01$10.2mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-07-01$20.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-02 to 2022-07-01$0.32us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-01-01 to 2022-07-01$0.65us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-02 to 2022-07-01$0.32us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-07-01$0.66us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-02 to 2022-07-0132,221,038 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-01-01 to 2022-07-0132,032,300 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-01-01 to 2022-07-01$24.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-01-01 to 2022-07-01$2.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2022-01-01 to 2022-07-01$3.5mus-gaap:PaymentsOfDividends
Share repurchases6 months2022-01-01 to 2022-07-01$3.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-07-01$61.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-07-01$114.2mus-gaap:AssetsCurrent
Total assetsAt period end2022-07-01$217.9mus-gaap:Assets
Current liabilitiesAt period end2022-07-01$51.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-07-01$61.1mus-gaap:Liabilities
Shareholders' equityAt period end2022-07-01$156.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000950170-22-016419. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.